Search clinical trials for: Ulcerative

Total 1557 results

Mayo Clinic

Completed

IBD and Women's Health Wellness Program

Inflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis

United States
InDex Pharmaceuticals

Terminated

The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis (CONCLUDE)

Ulcerative Colitis

Korea, Republic of, United Kingdom, United States, Mexico, Belgium, Netherlands, Denmark, Poland, Israel, Germany, France, Australia, Austria, Canada, Lithuania, Croatia, Italy, Romania, Turkey, Portugal, Slovakia, Hungary, Norway, Bosnia... and more
Children's Hospital of Eastern Ontario

Active, not recruiting

OptiMized REsistaNt Starch in Inflammatory Bowel Disease: The MEND Trial

Inflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis

Canada
Children's Hospital of Eastern Ontario

Active, not recruiting

Resistant Starch in Pediatric Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis)

Inflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis

Canada
Abivax S.A.

Active, not recruiting

Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis

Ulcerative Colitis

Belgium, Poland, Czechia, Hungary
Hospital of South West Jutland
UMC Utrecht; University of Southern Denmark

Active, not recruiting

The Contact Activation System and Ulcerative Colitis

Ulcerative Colitis

Denmark
Bausch Health Americas, Inc.

Active, not recruiting

Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative Colitis

Ulcerative Colitis

United States
Viome

Terminated

Systems Biology of Gastrointestinal and Related Diseases

Obesity | Gastritis | Irritable Bowel Syndrome | Gastric Cancer | Esophageal Cancer | Gastro Esophageal Reflux | Crohn Disease | GERD | NAFLD | Ulcerative Colitis | Eosinophilic Esophagitis | Gastric Ulcer | Duodenal Ulcer | Barrett Esophagus | Intestinal Metaplasia | Colon Polyp | Lymphocytic Colitis | IBS | SIBO | Gallstone Disease | Microscopic Colitis and other conditions

United States
GlaxoSmithKline

Withdrawn

A First Time in Human Study to Evaluate the Safety and Tolerability of GSK4381406 in Healthy Participants

Colitis, Ulcerative

United Kingdom
UMC Utrecht
Radboud University Medical Center; Elisabeth-TweeSteden Ziekenhuis

Terminated

The Nori Health App

Crohn Disease | Ulcerative Colitis | IBD

Netherlands
Beth Israel Deaconess Medical Center

Enrolling by invitation

High Definition Colonoscopy (HDC) vs. Dye Spraying Chromo-colonoscopy (DSC) in Screening Patients With Long-standing Inflammatory Bowel Disease (IBD)

Inflammatory Bowel Diseases | Ulcerative Colitis | Crohn Colitis | Indeterminate Colitis | Colon Dysplasia

United States
Janssen Research & Development, LLC

Completed

A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis (VEGA)

Colitis, Ulcerative

United States, Russian Federation, Australia, Poland, Germany, Brazil, Ukraine, Argentina, Mexico
University of Miami
Pfizer

Completed

Second Line Induction Therapy and Healthy Diet for Patients With Ulcerative Colitis

Ulcerative Colitis

United States
Morphic Therapeutic, Inc

Active, not recruiting

A Phase 2a Open-Label Study to Evaluate the Efficacy and Safety of MORF-057 in Adults With UC

Inflammatory Bowel Diseases | Colitis, Ulcerative

United States, Poland
National Institute of Allergy and Infectious Diseases...

Enrolling by invitation

Elemental Diet for Treatment of Inflammatory Bowel Disease in Patients With Chronic Granulomatous Disease

Chronic Granulomatous Disease | Inflammatory Bowel Disease

United States
University of Saskatchewan
Royal University Hospital Foundation

Withdrawn

Flaxseed Lignan-Enriched Complex (FLC) for the Treatment of Patients With Ulcerative Colitis (UC): A Pilot Assessment (FLC&UC)

Ulcerative Colitis

Canada
University of Minnesota

Completed

Dietary Impact on Intestinal Sulfate Metabolism

Healthy Nutrition

United States
Hoffmann-La Roche

Terminated

A Phase I Study Of Etrolizumab Followed By Open-Label Extension And Safety Monitoring In Pediatric Patients With Moderate To Severe Ulcerative Colitis Or Moderate To Severe Crohn's Disease (FENNEL)

Crohn's Disease | Ulcerative Colitis

Poland, United Kingdom, Belgium, Spain
University Medical Center Groningen
Bühlmann Laboratories AG; European Crohn´s and Colitis Organisation

Enrolling by invitation

De-escalation of Anti-TNF Therapy in Inflammatory Bowel Disease (FREE)

Inflammatory Bowel Diseases | Crohn Disease | Colitis, Ulcerative

Belgium, Netherlands, Spain
Pfizer
Arena is a wholly owned subsidiary of Pfizer

Completed

Etrasimod Dose-Ranging Versus Placebo as Induction Therapy Study in Adult Japanese Subjects With Moderately to Severely Active Ulcerative Colitis

Ulcerative Colitis

Japan
Washington University School of Medicine
Amgen

Completed

Blinatumomab Consolidation Post Autologous Stem Cell Transplantation in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)

Diffuse Large B Cell Lymphoma

United States
Galapagos NV
Gilead Sciences

Active, not recruiting

Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis (SELECTIONLTE)

Ulcerative Colitis

United States, Netherlands, Israel, Spain, Taiwan, Australia, Italy, Hong Kong, Singapore, Korea, Republic of, Canada, Germany, United Kingdom, New Zealand, Ireland, Poland, Romania, Croatia, Belgium, Japan, India, Malaysia, Sweden, F... and more
Schneider Children's Medical Center, Israel

Completed

Body Composition in Children With Inflammatory Bowel Disease

Crohn's Disease | Ulcerative Colitis

Israel
Takeda

Terminated

Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease

Crohn Disease | Colitis, Ulcerative

Korea, Republic of, Italy, India, Malaysia, Hungary, Serbia, Latvia, Australia, Estonia, Poland, South Africa, Czechia, Turkey, Bulgaria, New Zealand, Romania, Russian Federation, Ukraine
Zhongshan Hospital Xiamen University

Completed

The Effect of Intestinal Microbiota Transplantation for Inflammatory Bowel Diseases (IBD)

Inflammatory Bowel Disease(IBD)

China
Takeda

Active, not recruiting

A Study on How Vedolizumab is Given and the Outcomes for Adults With Inflammatory Bowel Disease (VARIETY-Belgium)

Inflammatory Bowel Diseases | Colitis, Ulcerative | Crohns Disease

Belgium
Pfizer
In Expanded Access, treating physicians are the Sponsors

Available

Provide Pre-approval Single Patient Expanded Access (Compassionate Use) of Etrasimod for Patients.

Colitis, Ulcerative
AstraZeneca

Terminated

Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis (Expedition)

Ulcerative Colitis | IBD

United States, Italy, Taiwan, Korea, Republic of, Germany, Spain, Russian Federation, Japan, South Africa, Hungary, Poland, Israel, Puerto Rico, Czechia, Ukraine, United Kingdom, Canada, India, Slovakia
Novartis Pharmaceuticals

Terminated

Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative Colitis

Colitis, Ulcerative

Russian Federation, Czechia, Bulgaria, Germany, Poland, Slovakia
AstraZeneca

Terminated

Open-label Extension Study of Brazikumab in Ulcerative Colitis (Expedition)

Ulcerative Colitis

Italy, United States, Taiwan, Germany, Poland, Israel, Puerto Rico, Czechia, South Africa, Japan, Korea, Republic of
Galapagos NV

Terminated

A Study Evaluating the Effect of Filgotinib Dose De-escalation in Participants With Ulcerative Colitis (UC) in Remission (CAPYBARA)

Ulcerative Colitis

United States, Germany, Korea, Republic of, Spain, France, Hungary, United Kingdom, Poland, Belgium, Czechia, Italy, South Africa, Taiwan
Osijek University Hospital
Josip Juraj Strossmayer University of Osijek

Completed

Real World Data on Vedolizumab Concentration and Outcomes in Inflammatory Bowel Disease (IBD) Patients Switching From Intravenous (IV) to Subcutaneous (SC) Vedolizumab in University Hospital Center Osijek

Inflammatory Bowel Diseases | Crohn Disease | Colitis, Ulcerative

Croatia
Children's Hospital Los Angeles

Active, not recruiting

The Effect of Therapeutic Fecal Transplant on the Gut Microbiome in Children With Ulcerative Colitis (FMT_UC)

Ulcerative Colitis

United States
Hoffmann-La Roche

Terminated

Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies (COTTONWOOD)

Ulcerative Colitis

Israel, Spain, United States, United Kingdom, Belgium, Korea, Republic of, Canada, Australia, Austria, Czechia, France, Italy, Netherlands, New Zealand, Russian Federation, Hungary, Singapore, India, Portugal, Serbia, Hong Kong, B... and more
AbbVie

Active, not recruiting

A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC)

Ulcerative Colitis (UC)

United States, Argentina, Australia, Austria, Belarus, Belgium, Bosnia and Herzegovina, Brazil, Canada, Chile, China, Colombia, Croatia, Czechia, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Japan, Korea, Republic... and more
Viome

Active, not recruiting

Microbial and Human Determinants of the Onset of IBD Flares

Crohn Disease | Ulcerative Colitis | Crohns Disease Aggravated | Crohn Disease in Remission | Irritable Bowel

United States
McMaster University
University of Manitoba; University of British Columbia; McGill University; University...

Active, not recruiting

Tofacitinib for Hospitalized Acute Severe Ulcerative Colitis Management (TRIUMPH)

Ulcerative Colitis Acute

Canada
Telavant, Inc.
Pfizer

Completed

Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis.

Colitis, Ulcerative

United States, Korea, Republic of, Belgium, Italy, Netherlands, Poland
Massachusetts General Hospital

Suspended

Adjunctive Treatment With Vitamin D3 in Patients With Active IBD (ACTIVATED)

Inflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis | IBD | Vitamin D3 Deficiency

United States
University of Erlangen-Nürnberg Medical School

Completed

Autologous Ex Vivo Expanded Regulatory T Cells in Ulcerative Colitis

Autoimmune Diseases | Ulcerative Colitis

Germany
Stacy A. Kahn

Completed

Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis and Pediatric Active Crohn's Colitis

Inflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis

United States
Pfizer
Arena is a wholly owned subsidiary of Pfizer

Completed

Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN)

Ulcerative Colitis

Japan
Janssen Cilag S.A.S.

Completed

Real-world Effectiveness of Ustekinumab in Participants Suffering From Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) With Extra-intestinal Manifestations or Immune-mediated Inflammatory Diseases (TENOR)

Crohn Disease | Colitis, Ulcerative

France
Boston Children's Hospital

Active, not recruiting

High Dose Interval Vitamin D Supplementation in Patients With IBD Receiving Remicade

Crohn Disease | Ulcerative Colitis | IBD

United States
Adaptive Biotechnologies

Terminated

ImmuneSense™ IBD Study

Inflammatory Bowel Diseases

United States
Bristol-Myers Squibb

Completed

A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative Colitis

Crohn Disease | Ulcerative Colitis

Romania, Italy, United States, Australia, Canada, China, Germany, Hungary, Japan, Netherlands, Poland, Portugal, Russian Federation, Spain, Taiwan, United Kingdom
Takeda

Active, not recruiting

A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Poland (VARIETY)

Crohn's Disease | Ulcerative Colitis | Inflammatory Bowel Disease (IBD)

Poland
Genentech, Inc.

Terminated

An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease

Crohn's Disease | Ulcerative Colitis

Germany, Italy, Poland, Russian Federation, Serbia, United States, Ukraine, Bulgaria, Georgia, Greece, Ireland, Moldova, Republic of, Spain, United Kingdom
Oppilan Pharma Ltd

Active, not recruiting

VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis

Colitis, Ulcerative

United States, Bulgaria, Czechia, France, Georgia, Germany, Hungary, India, Italy, Korea, Republic of, Lithuania, Poland, Serbia, Slovakia
Celltrion

Completed

CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Ulcerative Colitis (LIBERTY-UC)

Ulcerative Colitis

Poland

Search clinical trials for: Ulcerative

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations